ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in ESSA Pharma Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- −5 vs. Q2 2022
- Shares held
- 33.8M
- −3.98M (−10.5%) vs. Q2 2022
- Total value
- $62.2M
- −$56.8M (−47.8%) vs. Q2 2022
- New holders
- 10
- 13 more added
- Sold out
- 15
- 15 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 32 | $4.30M |
| Q2 2025 | 36 | $52.7M |
| Q1 2025 | 36 | $50.1M |
| Q4 2024 | 45 | $58.8M |
| Q3 2024 | 32 | $212.7M |
| Q2 2024 | 31 | $185.1M |
| Q1 2024 | 33 | $297.5M |
| Q4 2023 | 31 | $229.4M |
| Q3 2023 | 36 | $103.4M |
| Q2 2023 | 39 | $89.8M |
| Q1 2023 | 37 | $98.3M |
| Q4 2022 | 45 | $84.1M |
| Q3 2022 | 54 | $62.2M |
| Q2 2022 | 59 | $119.0M |
| Q1 2022 | 70 | $229.9M |
| Q4 2021 | 60 | $530.1M |
| Q3 2021 | 75 | $297.4M |
| Q2 2021 | 80 | $976.0M |
| Q1 2021 | 70 | $895.7M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding ESSA Pharma Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 8 | $0 | 0.00% | −8,656−99.9% | Reduced |
| Crewe Advisors LLC | 265 | $0 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 31 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 350 | $0 | 0.00% | +350 | New |
| Federation des caisses Desjardins du Quebec | 50 | $91 | 0.00% | 00.0% | Unchanged |
| Laurel Wealth Advisors LLC | 600 | $1.00K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 900 | $1.59K | 0.00% | 00.0% | Unchanged |
| Quantbot Technologies LP | 2,151 | $3.00K | 0.00% | +2,151 | New |
| Aquatic Capital Management LLC | 3,300 | $6.00K | 0.00% | +3,300 | New |
| Advisor Group Holdings, Inc. | 4,225 | $8.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5,765 | $10.0K | 0.00% | −1,630−22.0% | Reduced |
| Bessemer Group Inc | 6,852 | $12.0K | 0.00% | 00.0% | Unchanged |
| Hunting Hill Global Capital, LLC | 10,000 | $18.0K | 0.01% | +10,000 | New |
| Alta Wealth Advisors LLC | 11,285 | $21.0K | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 11,868 | $22.0K | 0.00% | +199+1.7% | Added |
| Tower Research Capital LLC (TRC) | 16,760 | $30.0K | 0.00% | −5,208−23.7% | Reduced |
| Geode Capital Management, LLC | 19,039 | $34.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 19,872 | $36.0K | 0.00% | +19,872 | New |
| XTX Topco Ltd | 23,338 | $42.0K | 0.01% | +23,338 | New |
| Alps Advisors Inc | 24,052 | $44.0K | 0.00% | −2,088−8.0% | Reduced |
| State Street Corp | 24,851 | $45.0K | 0.00% | −5,860−19.1% | Reduced |
| Goldman Sachs Group Inc | 24,531 | $45.0K | 0.00% | +12,792+109.0% | Added |
| Thrivent Financial for Lutherans | 31,337 | $56.0K | 0.00% | +31,337 | New |
| AlpInvest Partners B.V. | 39,930 | $73.0K | 0.02% | −66,461−62.5% | Reduced |
| Raymond James & Associates | 40,619 | $74.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 44,832 | $82.0K | 0.00% | −74,619−62.5% | Reduced |
| Cubist Systematic Strategies, LLC | 55,614 | $101.0K | 0.00% | +25,715+86.0% | Added |
| Acadian Asset Management LLC | 72,046 | $129.0K | 0.00% | +72,046 | New |
| JPMorgan Chase & Co | 73,668 | $134.0K | 0.00% | −206,057−73.7% | Reduced |
| CIBC World Markets Inc. | 77,236 | $141.0K | 0.00% | −17,342−18.3% | Reduced |
| Marshall Wace, LLP | 115,122 | $209.0K | 0.00% | +93,729+438.1% | Added |
| Renaissance Technologies LLC | 185,910 | $338.0K | 0.00% | +160,310+626.2% | Added |
| Walleye Capital LLC | 237,153 | $432.0K | 0.01% | +132,760+127.2% | Added |
| Omega Fund Management, LLC | 328,196 | $597.0K | 0.22% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 342,400 | $623.0K | 0.00% | +291,300+570.1% | Added |
| Two Sigma Investments, LP | 347,758 | $633.0K | 0.00% | +296,302+575.8% | Added |
| Woodline Partners LP | 382,282 | $696.0K | 0.01% | +382,282 | New |
| MPM Oncology Impact Management LP | 405,700 | $738.0K | 0.17% | −255,192−38.6% | Reduced |
| Millennium Management LLC | 406,761 | $740.0K | 0.00% | +80,031+24.5% | Added |
| Candriam Luxembourg S.C.A. | 417,532 | $760.0K | 0.01% | −149,811−26.4% | Reduced |
| D. E. Shaw & Co., Inc. | 499,833 | $910.0K | 0.00% | +159,207+46.7% | Added |
| Rock Springs Capital Management LP | 524,944 | $955.0K | 0.02% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 640,645 | $1.17M | 0.02% | +640,645 | New |
| Frazier Life Sciences Management, L.P. | 692,910 | $1.26M | 0.10% | 00.0% | Unchanged |
| Rhenman & Partners Asset Management AB | 375,000 | $1.35M | 0.14% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,042,531 | $1.90M | 0.00% | 00.0% | Unchanged |
| RTW Investments, LP | 1,311,294 | $2.39M | 0.06% | −1,325,898−50.3% | Reduced |
| PFM Health Sciences, LP | 1,478,252 | $2.69M | 0.10% | +516,536+53.7% | Added |
| Eventide Asset Management, LLC | 1,561,251 | $2.84M | 0.06% | −1,804,317−53.6% | Reduced |
| Morgan Stanley | 2,106,019 | $3.83M | 0.00% | −1,563,661−42.6% | Reduced |
| Avidity Partners Management LP | 2,460,000 | $4.48M | 0.10% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 2,640,539 | $4.81M | 0.65% | −1,528,260−36.7% | Reduced |
| Bellevue Group AG | 5,898,583 | $10.7M | 0.15% | +888,869+17.7% | Added |
| BVF Inc | 8,748,629 | $15.9M | 0.66% | +5,050,000+136.5% | Added |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −2,909,410−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −2,003,103−100.0% | Sold out |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −724,500−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −53,443−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −40,421−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −28,551−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −26,282−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −26,146−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −19,147−100.0% | Sold out |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | −14,605−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −11,353−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −599−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −132−100.0% | Sold out |